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ABSTRACT 
The new 2-arylquinoline-4-carboxylic acid derivatives 4(a-f) and 5(a-i), were tested by qualitative and quantitative methods 
on various bacterial and fungal strains and proved to be active at low concentrations against Gram-positive and Gram-
negative bacteria as well as fungi. The MIC values were determined for test compounds as well as for reference 
standards. Compounds 4b and 5d showed better antibacterial and antifungal activity than clinically prevalent drugs 
(Gentamicin, Ampicillin and Fluconazole) against Staphylococcus aureus and Candida albicans. The structures of 
newly synthesized compounds have been characterized on the basis of their spectroscopic data. The study revealed the 
potential of newly synthesized compounds as a novel group of antimicrobials. 
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Introduction  
The quinoline scaffold is prevalent in a variety of synthetic and natural compounds. Substituted quinolines are one of the 
oldest known classes of pharmaceutical agents and their relevance in chemotherapy especially against malaria is known 
[1-6]
. Beside antimalarials, a spectrum of other pharmacological activities 
[7-12]
 like  antimicrobial 
[13-15]
, antifungal 
[16,17]
 
antiamoebic 
[18]
 antileishmanial 
[19,20]
 antitumor 
[21-23]
 hypotensive 
[24]
 and antidepressant agents 
[25,26]
 has been the major 
reason for the development of novel and efficient synthesis of quinoline derivatives. Improvement of existing antimicrobial 
drugs and development of new ones is extremely necessary in today’s world, which is witnessing an increasing incidence 
of bacterial drug resistance. This has also triggered the publications of several simple and elegant derivatives of 
quinolones 
[27-32]
. Furthermore, several hydrazide-carboxamides 
[33]
, oxadiazoles 
[34]
 and indolin-2-ones 
[35,36]
 have been 
claimed to exhibit appreciable antimicrobial activity. As a part of our interest in identifying a larger number of bioactive 
quinolines and in continuation of our previous work 
[37]
 we have synthesized some new hydrazide-carboxamides, 
oxadiazole and isoindoline-1,3-diones of 2-arylquinoline-4-carbohydrazides to evaluate their in vitro antimicrobial activity. 
Results And Discussion 
Chemistry 
The synthetic chemical routes employed in producing 4(a-f) and 5(a-i) are portrayed in Scheme-1. The starting 2-
arylquinoline-4-carboxylic acids were prepared by a literature procedure utilizing well established Pfitzinger reaction from 
isatin and different α-methyl ketones in satisfactory yields. The acids were subsequently treated with thionyl chloride in 
refluxing benzene to give corresponding acid chlorides which were used directly to prepare the hydrazides 1(a-c) through 
reaction with hydrazine hydrate in refluxing ethanol.                                                                      
                                     Scheme 1 Synthesis of 4(a-f) and 5(a-i) from 2-substituted phenylquinoline-4-carbohydrazides
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    The hydrazides were characterized by their physical, analytical and spectral data. IR spectra of the hydrazides showed 
NH and C=O stretching bands at 3264-3356cm
-1
 and 1640-1662cm
-1
, respectively. The absorption bands associated with 
other functional groups appeared in the expected region. In the 
1
HNMR spectra of the hydrazides, the amine(NH2) proton 
appeared at 4.7-5.1 ppm as a sharp D2O exchangeable singlet, whereas a broad more downfield D2O exchangeable 
singlet at 9.8-10.1 ppm was characteristic of the NH proton (CONH group), the other protons appeared at the expected 
chemical shifts and integral values. Reaction of 1(a-c) with salicylaldehyde or 2-hydroxynapthaldehyde in ethanol in 
presence of catalytic amount of hydrochloric acid furnished N'-(2-hydroxybenzylidene)-2-(4-substituted phenyl)quinoline-4-
carbohydrazides or N'-((3-hydroxynaphthalen-2-yl)methylene)-2-(4-substituted phenyl) quinoline-4-carbohydrazides 2(a-f). 
Then the   reduction of 2(a-f) using sodium borohydride in methanol gave N'-(2-hydroxybenzyl)-2-(4-
substitutedphenyl)quinoline-4-carbohydrazides or N'-((3-hydroxy naphthalene-2-yl)methyl-2-(4-substituted phenyl) 
quinoline-4-carbohydrazides 3(a-f). The  internal Mannich reaction of 3(a-f) with formaldehyde in ethanol afforded N-(2H-
benzo[e][1,3] oxazin-3(4H)-yl)-2-(4-substitutedphenyl)quinoline-4-carboxamides or N-(2H-naphtho[2,3-e][1,3]oxazin-3(4H)-
yl)-2-(4-substitutedphenyl)quinoline-4-carboxamides 4(a-f). The structures of all the products were in good agreement with 
spectral data and elemental analysis. The above series of reactions is suitable for coupling quinazoline moiety with 
benzoxazine or naphthoxazine moiety through –CONH-bridge. 
    On the other hand, the condensation of 1(a-c) with various substituted acids (quinoline-4-carboxylic acids, furoic acid 
and phthalimidoacetic acid) in the presence of phosphorus oxychloride afforded 2,5-bis(2-substituted phenylquinolin-4-yl)-
1,3,4-oxadiazoles or 2-(furan-2-yl)-5-(2-(4-substituted phenyl)quinolin-4-yl)-1,3,4-oxadiazoles or 2-((5-(2-(4-substituted 
phenyl) quinolin-4-yl)-1,3,4-oxadiazol-2-yl)methyl)isoindoline-1,3-diones 5(a-i). The IR spectra of 5 showed disappearance 
of absorption band at 1640-1662cm
-1
 due to C=O stretching vibration and appearance of a band at 1093-1153cm
-1
 region 
attributable to C-O-C vibrations providing a strong evidence for the formation of the titled compounds. In the 
1
HNMR 
spectrum of 5c, the signal of CH2-N of two proton of isoindole appeared as a singlet at 3.89 ppm. The signal of protons of 
isoindole ring and aromatic protons appeared as a complex multiplet in the region 7.38-8.09 ppm.  In the 
13
CNMR of 5c, 
the CH2-N of isoindole ring carbon appeared at 42.6 ppm, carbonyl carbon peak appeared at 167.2 ppm. The N=C-O of 
oxadiazole carbon appeared at 162.4 ppm and remaining aromatic carbons peak appeared at region 120-149.8 ppm. The 
structures of all the products were in good agreement with spectral data and elemental analysis.  
Experimental 
Melting points were determined with an Electro thermal melting point apparatus and are uncorrected. Reactions were 
monitored by TLC, performed on silica gel glass plates, visualization on TLC were achieved by iodine indicator. I.R. 
spectra (potassium bromide) were recorded on Perkin-Elmer FTIR spectrophotometer (ν max in cm
-1
); 
1
H and 
13
C-NMR 
spectra were recorded on Bruker 200/300 MHz instruments using CDCl3 and DMSO-d6 as solvents. Chemical shifts (δ) 
are reported in ppm downfield from internal TMS standard. ESI MS mass spectra were recorded on a Va 70-70H mass 
spectrometer (Manchester, UK) at 70 eV, with a trap current of 200 μA and 4 kV of acceleration voltage and ESI mode 
positive ion trap detector. Elemental Analysis was performed on a Perkin-Elmer 2400 series II elemental CHNS analyzer. 
All chemicals and reagents were obtained from Aldrich, Lancaster, Merck, Sdfine or Spectrochem Pvt. Ltd and were used 
without further purification. 
2-arylquinoline-4-carboxylic acids 
[38-40]
 and 2-arylquinoline-4-carbohydrazides 1(a-c) 
[41-45]
 were prepared according to 
literature procedures.  
General Method for the synthesis of N'-(2-hydroxybenzylidene)-2-(4-substituted phenyl) quinoline-4-
carbohydrazide / N'-((3-hydroxynapthalen-2-yl)methylene)-2-(4-substituted phenyl) quinoline-4-carbohydrazide 
2(a-f). 
2-(4-substituted phenyl) quinoline-4-carbohydrazide 1 (0.01mol) and salicylaldehyde or 2-hydroxynaphthaldehyde (0.01 
mol) were refluxed in ethanol (50 mL) containing two drops of concentrated hydrochloric acid for 2 h. Crystalline solids 
which separated on cooling were collected and recrystallised from ethanol. 
N'-(2-hydroxybenzylidene)-2-phenylquinoline-4-carbohydrazide (2a):  
Pale yellow solid (Ethanol) (This compound was prepared by the reaction of 2-phenylquinoline-4-carbohydrazide 1a 
(0.01mol) and salicylaldehyde (0.01 mol) following the above general procedure. It was obtained as a pale yellow solid.); 
yield ~87 %; Rf value: 0.46 (9.0:1.0, Benzene: Acetone); mp 212-214
0
C; IR (KBr) νmax 3402, 3260, 1660, 1620,1588 cm
-
1
; 
1
HNMR (DMSO-d6): δ = 6.88-8.01(m, 14H, ArH), 8.58(s, 1H, CH), 10.01(s, 1H, OH), 11.12(s, 1H, NH ); EIMS m/z 
367(M+), 290, 232, 204, 163. Anal. Calcd. for C23H17N3O2: C, 75.20; H, 4.63; N, 11.44. Found: C: 75.00; H, 4.61, N, 11.41. 
 
2-(4-Chlorophenyl)-N'-(2-hydroxybenzylidene)quinoline-4-carbohydrazide (2b):  
Pale yellow solid (Ethanol) (This compound was prepared by the reaction of 2-(4-chlorophenyl) quinoline-4-
carbohydrazide 1b (0.01mol) and salicylaldehyde (0.01 mol) following the above general procedure.It was obtained as a 
pale yellow solid.); yield ~82%; Rf value: 0.43 (9.0: 1.0, Benzene: Acetone); mp 253-254
0
C; IR (KBr) νmax 3410, 3217, 
1662, 1621, 1589, 726 cm
-1
; 
1
HNMR (DMSO-d6): δ = 7.04-8.23 (m, 13H, ArH), 8.64 (s, 1H, CH), 10.05 (s, 1H, OH), 11.21 
(s, 1H, NH); EIMS m/z 401(M+), 403(M+1), 290, 266, 238, 163, 111; Anal. Calcd. for C23H16ClN3O2: C, 68.82; H, 3.99; N, 
10.47. Found: C, 69.00; H, 4.01; N, 10.50. 
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N'-(2-hydroxybenzylidene)-2-p-tolylquinoline-4-carbohydrazide (2c):  
Greenish yellow solid (Ethanol) (This compound was prepared by the reaction of 2-(4-methylphenyl) quinoline-4-
carbohydrazide 1c (0.01mol) and salicylaldehyde (0.01 mol) following the above general procedure. It was obtained as a 
greenish yellow solid.); yield ~87%; Rf value: 0.42 (8.5: 1.5, Benzene: Acetone); mp 234-236
0
C; IR (KBr) νmax 3421, 
3316, 1664, 1628, 1582, 706 cm
-1
; 
1
HNMR (DMSO-d6): δ = 2.28 (s, 3H, CH3), 6.99-8.17 (m, 13H, ArH), 8.48 (s, 1H, CH), 
9.49 (s, 1H, OH), 10.40 (s, 1H, NH). EIMS m/z 381 (M+), 367, 290, 232, 204, 163; Anal. Calcd. for C24H19N3O2: C, 75.59; 
H, 4.98; N, 11.02. Found: C, 75.78; H, 5.02; N, 11.05. 
 
N'-((3-hydroxynaphthalen-2-yl)methylene)-2-phenylquinoline-4-carbohydrazide (2d):  
Light yellow solid (Ethanol) (This compound was prepared by the reaction of 2-phenylquinoline-4-carbohydrazide 1a 
(0.01mol) and 2-hydroxynaphthaldehyde (0.01 mol) following the above general procedure. It was obtained as a light 
yellow solid.); yield ~89%, Rf value, 0.26 (8.5: 1.5, Benzene: Acetone); mp 226-227
0
C; IR (KBr) νmax 3400, 3269, 1662, 
1625, 1580 cm
-1
; 
1
HNMR (DMSO-d6): δ = 7.21-8.48 (m, 16H, ArH), 8.61 (s, 1H, CH), 11.18 (s, 1H, OH), 12.28(s, 1H, NH). 
IR (KBr) νmax: 3400, 3269, 1662, 1625, 1580 cm-1 ; EIMS m/z 417(M+), 340, 232, 213, 204, 185; Anal. Calcd. for 
C27H19N3O2: C,77.69; H, 4.55; N, 10.07. Found: C, 77.41; H, 4.51; N, 10.09. 
 
2-(4-chlorophenyl)-N'-((3-hydroxynaphthalen-2-yl)methylene)quinoline-4-carbohydrazide (2e): 
Brown yellow crystals (Ethanol) (This compound was prepared by the reaction of 2-(4- chloro phenyl) quinoline-4-
carbohydrazide 1b (0.01mol) and 2-hydroxynaphthaldehyde (0.01 mol) following the above general procedure.It was 
obtained as a brown yellow crystals.); yield ~78%; Rf value: 0.27 (8.0: 2.0, Benzene: Acetone); mp 290-291
0
C; IR (KBr) 
νmax 3406, 3276, 1664, 1625, 1581, 723 cm
-1
; 
1
HNMR (DMSO-d6): δ = 7.06-8.42 (m, 15H, ArH), 8.78 (s, 1H, CH), 9.98 
(s, 1H, OH), 11.2 (s, 1H, NH); EIMS m/z 451(M+), 453(M+1), 266, 238, 213, 185, 111; Anal. Calcd. for C27H18ClN3O2: C, 
71.84; H, 3.99; N, 9.31. Found: C, 72.16; H, 4.08; N, 9.35. 
 
N'-((3-hydroxynaphthalen-2-yl)methylene)-2-p-tolylquinoline-4-carbohydrazide (2f): 
Brown yellow crystals (Ethanol) (This compound was prepared by the reaction of 2-(4-methyl phenyl) quinoline-4-
carbohydrazide 1c (0.01mol) and 2-hydroxynaphthaldehyde (0.01 mol) following the above general procedure.It was 
obtained as a brown yellow crystals.); yield ~76%; Rf value: 0.43 (8.0: 2.0, Benzene: Acetone); mp 244-245
0
C; IR (KBr) 
νmax 3413, 3322, 1660, 1620, 1586, 704 cm
-1
; 
1
HNMR (DMSO-d6): δ = 2.16 (s, 3H, CH3), 6.99-8.23 (m, 15H, ArH), 8.70 
(s, 1H, CH-N), 9.80 (s, 1H, OH), 10.70 (s, 1H, NH); EIMS m/z 431(M+), 340, 261, 246, 218, 91; Anal. Calcd. for 
C28H21N3O3: C, 77.95; H, 4.87; N, 9.74. Found: C, 77.72; H, 4.84; N, 9.92. 
 
General Method for the synthesis of N'-(2-hydroxybenzyl)-2-(4-substituted phenyl)quinoline-4-carbohydrazide/N'-
((3-hydroxynapthalen-2-yl)methyl-2-(4-substituted phenyl)quinoline-4-carbohydrazide 3(a-f). 
Sodium borohydride (0.01 mol) was added to a solution of N'-(2-hydroxybenzylidene)-2-(4-substituted phenyl)quinoline-4-
carbohydrazide or N'-((3-hydroxynaphthalene-2-yl ) methylene)-2-(4-substituted phenyl)quinoline-4-carbohydrazide 2 
(0.005 mol) in methanol (25 mL) and the reaction mixture was stirred for 4 h. It was then poured in to cold water (50 mL). 
The product, which separated as a solid, was filtered and washed with water. The crude products were purified by 
crystallization from ethanol. 
 
N'-(2-hydroxybenzyl)-2-phenylquinoline-4-carbohydrazide (3a):  
Brown solid (Ethanol)(To synthesized 3a sodium borohydride (0.01 mol) was added to a solution of N'-(2-
hydroxybenzylidene)-2-phenylquinoline-4-carbohydrazide 2a (0.005 mol) in methanol (25 mL) and then followed the above 
general procedure. It was obtained as a brown solid.); yield ~79 %; Rf value: 0.34 (9.0: 1.0 Benzene: Acetone); mp 187-
189
0
C; IR (KBr) νmax 3398, 3220, 3135, 1643, 1624, 1540 cm
-1
; 
1
HNMR (DMSO-d6): δ = 4.01 (s, 2H, CH2), 5.2 (s, 1H, 
OH), 6.91-8.11 (m, 14H, ArH), 9.29 (s, 1H, NH-CH2), 10.08 (s, 1H, NH-CO); Anal. Calcd. for C23H19N3O2: C, 74.79; H, 
5.14; N, 11.38. Found: C, 75.59; H, 5.10; N, 11.35. 
 
2-(4-chlorophenyl)-N'-(2-hydroxybenzyl)quinoline-4-carbohydrazide (3b):  
Light brown crystals (Ethanol) (To synthesized 3b sodium borohydride (0.01 mol) was added to a solution of 2-(4-
Chlorophenyl)-N'-(2-hydroxybenzylidene)quinoline-4-carbohydrazide 2b (0.005 mol) in methanol (25 mL) and then 
followed the above general procedure. It was obtained as a light brown crystals.); yield: 69 %; Rf value: 0.30 (9.0: 1.0 
Benzene: Acetone); mp 243-244
0
C; IR (KBr) νmax 3406, 3227, 3148, 1648, 1598, 1572, 724 cm
-1
; 
1
HNMR (DMSO-d6): δ 
= 4.15 (s, 2H, CH2), 5.94 (s, 1H, OH), 6.81-8.37(m, 13H, ArH), 9.84 (s, 1H, NH-CH2), 11.01(s, 1H, NH-C-O); Anal. Calcd. 
for C23H16ClN3O2: C, 68.48; H, 4.46; N, 10.42. Found: C, 68.65; H, 4.49; N, 10.44. 
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N'-(2-hydroxybenzyl)-2-p-tolylquinoline-4-carbohydrazide (3c):  
Light brown solid (Ethanol) (To synthesized 3c sodium borohydride (0.01 mol) was added to a solution of N'-(2-
hydroxybenzylidene)-2-p-tolylquinoline-4-carbohydrazide 2c  (0.005 mol) in methanol (25 mL) and then followed the above 
general procedure. It was obtained as a light brown solid.); yield ~75 %; Rf value: 0.43 (9.0: 1.0 Benzene: Acetone); mp 
232
0
C; IR (KBr) νmax 3412, 3312, 3167, 1658, 1608, 1578, 702 cm
-1
; 
1
HNMR (DMSO-d6): δ = 2.03 (s, 3H, CH3), 3.98 (s, 
2H, CH2), 6.49 (s, 1H, OH), 6.79-8.27 (m, 13H, ArH), 7.83 (s, 1H, NH-CH2, D2O-exchangeable), 9.89 (s, 1H, NH-CO); 
Anal. Calcd. for C24H12N3O2: C, 75.19; H, 5.48; N, 10.96. Found: C, 75.00; H, 5.46; N, 10.92. 
  
N'-((3-hydroxynaphthalen-2-yl)methyl)-2-phenylquinoline-4-carbohydrazide (3d):  
Light brown solid (Ethanol) (To synthesized 3d sodium borohydride (0.01 mol) was added to a solution of N'-((3-
hydroxynaphthalen-2-yl)methylene)-2-phenylquinoline-4-carbohydrazide 2d (0.005 mol) in methanol (25 mL) and then 
followed the above general procedure. It was obtained as a light brown solid.); yield ~71 %; Rf value: 0.38 (9.0: 1.0 
Benzene: Acetone); mp 196-197
0
C; IR (KBr) νmax 3396, 3237, 3123, 1668, 1629, 1548 cm
-1
; 
1
HNMR (DMSO-d6): δ = 
4.08 (s, 2H, CH2), 5.89 (s, 1H, OH), 6.92-8.04 (m, 16H, ArH), 9.69 (s, 1H, NH-CH2), 10.20 (s, 1H, NH-CO); Anal. Calcd. for 
C27H21N3O3: C, 77.32; H, 5.01; N, 10.02. Found: C, 77.51; H, 5.02; N, 10.04. 
 
2-(4-chlorophenyl)-N'-((3-hydroxynaphthalen-2-yl)methyl)quinoline-4-carbohydrazide (3e): 
Light brown solid (Ethanol) (To synthesized 3e sodium borohydride (0.01 mol) was added to a solution of 2-(4-
chlorophenyl)-N'-((3-hydroxynaphthalen-2-yl)methylene)quinoline-4-carbohydrazide 2e (0.005 mol) in methanol (25 mL) 
and then followed the above general procedure. It was obtained as a light brown solid.); yield ~67 %; Rf value: 0.54 (8.0: 
2.0 Benzene: Acetone); mp 269-271
0
C; IR (KBr) νmax 3409, 3225, 3175, 1663, 1612, 1575, 722 cm
-1
; 
1
HNMR (DMSO-
d6): δ = 4.21(s, 2H, CH2), 6.23 (s, 1H, OH), 6.76-8.19 (m, 15H, ArH), 9.96 (s, 1H, NH-CH2), 11.12 (s, 1H, NH-CO); Anal.  
Calcd. for C27H20ClN3O3: C, 71.53; H, 4.41; N, 9.27. Found: C, 71.36; H, 4.40; N, 9.25. 
 
N'-((3-hydroxynaphthalen-2-yl)methyl)-2-p-tolylquinoline-4-carbohydrazide (3f): 
Light brown crystals (Ethanol) (To synthesized 3f sodium borohydride (0.01 mol) was added to a solution of N'-((3-
hydroxynaphthalen-2-yl)methylene)-2-p-tolylquinoline-4-carbohydrazide 2f (0.005 mol) in methanol (25 mL) and then 
followed the above general procedure. It was obtained as a light brown crystals.); yield ~79 %; Rf value: 0.49 (9.0: 1.0 
Benzene: Acetone); mp 278
0
C; IR (KBr) νmax 3418, 3316, 3183, 1656, 1612, 1569, 706 cm
-1
; 
1
HNMR (DMSO-d6): δ = 
2.08 (s, 3H, CH3), 4.19 (s, 2H, CH2), 6.63 (s, 1H, OH), 6.84-8.09 (m, 15H, ArH), 7.73 (s, 1H, NH-CH2, D2O-exchangeable), 
8.87(s, 1H, NH-CO); Anal. Calcd. for C28H23N3O2: C, 77.59; H, 5.31; N, 9.69. Found: C, 77.41; H, 5.29; N, 9.66. 
 
General Method for the synthesis of N-(2H-benzo[e][1,3]oxazin-3(4H)-yl)-2-(4-substituted phenyl)quinoline-4-
carboxamide/N-(2H-naphtho[2,3-e][1,3]oxazin-3(4H)-yl)-2-(4-substituted phenyl)quinoline-4-carboxamide 4(a-f). 
Compounds 3 (0.002 mol) and formalin (1ml 37%) were refluxed in ethanol (15ml) for 5 h. The reaction mixture was 
concentrated under reduced pressure and the resultant solution was poured on to crushed ice. The crude products were 
recrystallized with appropriate solvents. 
 
N-(2H-benzo[e][1,3]oxazin-3(4H)-yl)-2-phenylquinoline-4-carboxamide (4a):  
Brown solid (This compound was prepared by the reaction of N'-(2-hydroxybenzyl)-2-phenylquinoline-4-carbohydrazide 
(3a) (0.002 mol) and formalin (1ml 37%) and then followed the above general procedure. It was obtained as a brown 
solid.); yield ~78 %; Rf value: 0.44 (9.0: 1.0 Benzene: Acetone); mp 182
0
C; IR (KBr) νmax 3310, 1667, 1582, 1548, 1115 
cm
-1
; 
1
HNMR (DMSO-d6): δ = 3.93 (s, 2H, N-CH2-C), 5.09 (s, 2H, N-CH2-O), 6.87-8.04 (m, 14H, ArH), 8.40 (s, 1H, NH); 
13
CNMR (DMSO-d6): δ = 122.4-148.1 (quinoline and phenyl), 162.8 (C=O), 56.2 (N-CH2-C), 79.8 (N-CH2-O); EIMS m/z 
381(M+), 247, 232; Anal. Calcd. for C24H19N3O2: C, 75.59; H, 4.98; N, 11.02. Found: C, 75.98; H, 5.01; N, 11.08. 
 
N-(2H-benzo[e][1,3]oxazin-3(4H)-yl)-2-(4-chlorophenyl)quinoline-4-carboxamide (4b).  
Brown crystals (This compound was prepared by the reaction of 2-(4-chlorophenyl)-N'-(2-hydroxybenzyl)quinoline-4-
carbohydrazide (3b) (0.002 mol) and formalin (1ml 37%) following the above general procedure. It was obtained as a 
brown crystals.); yield ~74%; Rf value:0.58 (9.0: 1.0 Benzene: Acetone); mp 198
0
C; IR (KBr) νmax 3182, 1653, 1575, 
1545, 1093, 928 cm
-1
; 
1
HNMR (DMSO-d6): δ = 3.99 (s, 2H, N-CH2-C), 5.03 (s, 2H, N-CH2-O), 7.16-8.09 (m, 13H, ArH), 
8.96 (s, 1H, NH); 
13
CNMR (DMSO-d6): δ = 123.5-147.9 (quinoline and phenyl), 160.8 (C=O), 54.2 (N-CH2-C), 83.2 (N-
CH2-O); EIMS m/z 415(M+), 417(M+1), 339, 309, 281, 238; Anal. Calcd. for C24H18ClN3O2: C, 69.39; H, 4.33; N, 10.02. 
Found: C, 69.06; H, 4.31; N, 10.07. 
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N-(2H-benzo[e][1,3]oxazin-3(4H)-yl)-2-p-tolylquinoline-4-carboxamide (4c):  
Reddish brown solid (This compound was prepared by the reaction of N'-(2-hydroxybenzyl)-2-p-tolylquinoline-4-
carbohydrazide (3c) (0.002 mol) and formalin (1ml 37%) following the above general procedure.It was obtained as a 
reddish brown solid.); yield ~69%; Rf value: 0.52 (9.0: 1.0 Benzene: Acetone); mp 185-186
0
C; IR (KBr) νmax 3326, 1660, 
1595, 1586, 1150, 704 cm
-1
; 
1
HNMR (DMSO-d6): δ = 2.50 (s, 2H, CH3), 3.76 (s, 2H, N-CH2-C), 5.19 (s, 2H, N-CH2-O), 
8.46 (s, 1H, NH), 6.93-8.01 (m, 13H, ArH); 
13
CNMR (DMSO-d6): δ = 20.09 (-CH3), 52.8 (N-CH2-N), 87.8 (N-CH2-O), 121-
149.2 (quinoline and phenyl), 159.8 (C=O); EIMS m/z 395(M+), 246, 218, 106; Anal. Calcd. for C25H21N3O2: C, 75.94; H, 
5.31; N, 10.63. Found: C, 75.18; H, 5.26; N, 10.52. 
 
N-(2H-naphtho[2,3-e][1,3]oxazin-3(4H)-yl)-2-phenylquinoline-4-carboxamide (4d): 
Reddish brown crystals (This compound was prepared by the reaction of N'-((3-hydroxynaphthalen-2-yl)methyl)-2-
phenylquinoline-4-carbohydrazide (3d) (0.002 mol) and formalin (1ml 37%) following the above general procedure.  It was 
obtained as a reddish brown crystals.); yield ~66%; Rf value: 0.46 (9.0: 1.0 Benzene: Acetone); mp 224-227
0
C; IR (KBr) 
νmax 3276, 1670, 1618, 1542, 1147cm
-1
; 
1
HNMR (DMSO-d6): δ = 3.96 (s, 2H, N-CH2-C), 5.16 (s, 2H, N-CH2-O), 7.11-8.21 
(m, 16H, ArH), 8.92 (s, 1H, NH); 
13
CNMR (DMSO-d6): δ = 49.8 (N-CH2-C), 91.8 (N-CH2-O), 109-151.2 (quinoline and 
phenyl), 162.2 (C=O); EIMS m/z 431(M+), 275, 232, 227, 204; Anal. Calcd. for C28H21N3O2: C, 77.95; H, 4.87; N, 9.74. 
Found: C, 78.13; H, 4.88; N, 9.76. 
 
2-(4-chlorophenyl)-N-(2H-naphtho[2,3-e][1,3]oxazin-3(4H)-yl)quinoline-4-carboxamide (4e):  
Dark brown crystals (This compound was prepared by the reaction of 2-(4-chlorophenyl)-N'-((3-hydroxynaphthalen-2-
yl)methyl)quinoline-4-carbohydrazide (3e) (0.002 mol) and formalin (1ml 37%) following the above general procedure.  It 
was obtained as a dark brown crystals.); yield ~74%;  Rf value: 0.42 (8.0: 2.0 Benzene: Acetone); mp 218-219
0
C; IR (KBr) 
νmax 3306, 1658, 1604, 1548, 1125, 924 cm
-1
; 
1
HNMR (DMSO-d6): δ = 3.89 (s, 2H, N-CH2-C), 4.98 (s, 2H, N-CH2-O), 
7.23-8.37 (m, 15H, ArH), 8.98 (s, 1H, NH); 
13
CNMR (DMSO-d6): δ = 51.6 (N-CH2-C), 88.2 (N-CH2-O), 104-149.2 (quinoline 
and phenyl), 158.9 (C=O); EIMS m/z 465(M+), 467(M+1), 354, 295, 266, 238; Anal.  Calcd. for C28H20ClN3O2: C, 72.25; H, 
4.30; N, 9.03. Found: C, 72.00; H, 4.33; N, 9.09. 
 
N-(2H-naphtho[2,3-e][1,3] oxazin-3(4H)-yl)-2-p-tolylquinoline-4-carboxamide (4f): 
 Light brown solid (This compound was prepared by the reaction of N'-((3-hydroxynaphthalen-2-yl)methyl)-2-p-
tolylquinoline-4-carbohydrazide (3f) (0.002 mol) and formalin (1ml 37%) following the above general procedure. It was 
obtained as a light brown solid.); yield ~73 %; Rf value: 0.54 (9.0: 1.0 Benzene: Acetone); mp 233-236
0
C; IR (KBr) νmax 
3312, 1667, 1614, 1549, 1123, 701 cm
-1
; 
1
HNMR (DMSO-d6): δ = 2.44 (s, 3H, CH3), 3.98(s, 2H, N-CH2-C), 5.10 (s, 2H, N-
CH2-O), 7.33-8.18 (m, 15H, ArH), 8.86 (s, 1H, NH); 
13
CNMR (DMSO-d6): δ = 21.01 (-CH3), 51.6 (N-CH2-C), 88.7 (N-CH2-
O), 118-147.9 (quinoline and phenyl), 163.5 (C=O); EIMS m/z 445(M+), 303, 261, 246, 218, 199. Anal. Calcd. for 
C29H23N3O2: C, 78.20; H, 5.16; N, 9.43. Found: C, 77.85; H, 5.15; N, 9.39. 
 
General Method for the preparation of 5(a-i). 
A mixture of 2-(4-substituted phenyl)-quinoline-4-carbohydrazide 1 (0.01 mol), quinoline-carboxylic acid, furoic acid or 
phthalimido acetic acid (0.01 mol) and phosphorus oxychloride (10 ml) was refluxed ~ 12h. The reaction mixture was 
cooled and allowed to stand at room temperature for 2 h. It was then poured on to crushed ice. The solid thus obtained 
were collected and treated with sodium bicarbonate solution (5%), then with water, filtered and recrystalised from mixture 
of ethanol and dimethyl formamide (2:1) to get compounds 5(a-i). 
 
2,5-bis(2-phenylquinolin-4-yl)-1,3,4-oxadiazole (5a):  
Light brown crystals [Ethanol and Dimethyl Formamide (2:1)] To synthesized 5a mixture of 2 -phenyl-quinoline-4-
carbohydrazide 1a (0.01 mol), quinoline-carboxylic acid (0.01 mol) and phosphorus oxychloride (10 ml) was refluxed ~ 12h 
and then followed the above general procedure. It was obtained as a light brown crystals [Ethanol and Dimethyl 
Formamide (2:1)]; yield ~78 %; Rf value: 0.34 (8.0: 2.0 Benzene: Acetone); mp 208-209
0
C; IR (KBr) νmax 3021, 1595, 
1529, 1153 cm
-1
;  
1
HNMR (CDCl3): δ = 6.8-8.2 (m, 20H, ArH); 
13
CNMR (CDCl3): δ = 124-152.4 (quinoline and phenyl), 
162.5 (O-C=N of oxadiazloe); EIMS m/z 476(M+), 437, 322, 246, 230, 204; Anal. Calcd. for C32H20N4O: C, 80.67; H, 4.20; 
N, 11.26. Found: C, 81.01; H, 4.31; N, 11.81. 
 
2-(furan-2-yl)-5-(2-phenylquinolin-4-yl)-1,3,4-oxadiazole (5b):  
Dark brown crystals [Ethanol and Dimethyl Formamide (2:1)] (To synthesized 5b mixture of 2- phenyl-quinoline-4-
carbohydrazide 1a (0.01 mol), furoic acid (0.01 mol) and phosphorus oxychloride (10 ml) was refluxed ~ 12h and then 
followed the above general procedure. It was obtained as a dark brown crystals.; yield ~73 %; Rf value: 0.26 (9.0: 1.0 
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Benzene: Acetone); mp 165-167
0
C; IR (KBr) cm
-1
 νmax 3099, 2920, 1632, 1608, 1108 cm
-1
 ; 
1
HNMR (CDCl3): δ = 7.17-
8.67 (m, 13H, ArH);  
13
CNMR (CDCl3): δ = 104-154.8 (furan, quinoline and phenyl), 158.5-164.2 (O-C=N of oxadiazole); 
EIMS m/z 339(M+), 272, 262, 204, 135; Anal. Calcd. for C21H13N3O2: C, 74.333; H, 3.83; N, 12.38. Found: C, 73.90; H, 
3.80; N, 12.31. 
. 
2-((5-(2-phenylquinolin-4-yl)-1,3,4-oxadiazol-2-yl)methyl)isoindoline-1,3-dione (5c):  
Dark brown solid [Ethanol and Dimethyl Formamide (2:1)](To synthesized 5c mixture of 2-phenyl-quinoline-4-
carbohydrazide 1a (0.01 mol), phthalimido acetic acid (0.01 mol) and phosphorus oxychloride (10 ml) was refluxed ~ 12h 
and then followed the above general procedure. It was obtained as a dark brown solid.; yield ~67 %; Rf value: 0.40 (8.0: 
2.0 Benzene: Acetone); mp 224
0
C; IR (KBr) cm
-1
 3015, 2993, 1680, 1633, 1582, 1098 cm
-1
; 
1
HNMR (CDCl3): δ = 3.89 (s, 
2H, CH2-N of isoindole), 7.08-8.19 (m, 14H, ArH); 
13
CNMR (CDCl3): δ = 42.6 (CH2-N), 120-149.8 (quinolone, isoindoline 
and phenyl), 162.4 (N=C-O), 167.2 (C=O); EIMS m/z 432(M+), 328, 244, 228, 204, 188; Anal. Calcd. for C24H16N4O3: C, 
72.22; H, 3.70; N, 12.96. Found: C, 72.55; H, 3.72; N, 13.02. 
 
2-(2-(4-chlorophenyl)quinolin-4-yl)-5-(2-phenylquinolin-4-yl)-1,3,4-oxadiazole (5d): 
Reddish brown crystals [Ethanol and Dimethyl Formamide (2:1)](To synthesized 5d mixture of 2-(4-chloro phenyl)-
quinoline-4-carbohydrazide 1b (0.01 mol), quinoline-carboxylic acid (0.01 mol) and phosphorus oxychloride (10 ml) was 
refluxed ~ 12h and then followed the above general procedure. It was obtained as a reddish brown crystals.); yield ~69 %; 
Rf value: 0.36 (9.0: 1.0 Benzene: Acetone); mp 212-213
0
C; IR (KBr) νmax 3094, 1627, 1593, 1142, 740 cm
-1
; 
1
HNMR 
(CDCl3): δ = 7.08-8.6 (m, 19H, Ar-H ); 
13
CNMR (CDCl3): δ = 120.01-151.8 (quinoline and phenyl), 165.2 (N=C-O of 
oxadiazole); EIMS m/z 510(M+), 512(M+1), 433, 399, 246, 238, 111; Anal. Calcd. for C32H19ClN4O: C, 75.29; H, 3.72; N, 
10.18. Found: C, 75.59; H, 3.74; N, 11.02. 
 
2-(2-(4-chlorophenyl)quinolin-4-yl)-5-(furan-2-yl)-1,3,4-oxadiazole (5e):  
Brown crystals [Ethanol and Dimethyl Formamide (2:1)] (To synthesized 5e mixture of 2-(4-chlorophenyl)-quinoline-4-
carbohydrazide 1b (0.01 mol), furoic acid (0.01 mol) and phosphorus oxychloride (10 ml) was refluxed ~ 12h and then 
followed the above general procedure. It was obtained as a brown crystals.); yield ~77 %; Rf value: 0.34 (9.0: 1.0 
Benzene: Acetone); mp 178
0
C; IR (KBr) νmax 3082, 1626, 1598, 1148, 732 cm
-1
;  
1
HNMR (CDCl3): δ = 6.98-8.59 (m, 12H, 
Ar-H); 
13
CNMR (CDCl3): δ = 110-149.2 (furan, quinoline and phenyl), 153-161.5 (N=C-O of oxadiazole); EIMS m/z 
373(M+), 375(M+1), 345, 294, 280, 266, 238; Anal. Calcd. for C21H12ClN3O2 : C, 67.55; H, 3.21; N, 11.26. Found: C, 
67.92; H, 3.23; N, 11.32. 
 
2-((5-(2-(4-chlorophenyl)quinolin-4-yl)-1,3,4-oxadiazol-2-yl)methyl) isoindoline-1,3-dione (5f):  
Light brown crystals [Ethanol and Dimethyl Formamide (2:1)](To synthesized 5f mixture of 2-(4- chlorophenyl)-quinoline-4-
carbohydrazide 1b  (0.01 mol), phthalimido acetic acid (0.01 mol) and phosphorus oxychloride (10 ml) was refluxed ~ 12h 
and then followed the above general procedure. It was obtained as a light brown crystals.); yield ~74 %; Rf value: 0.28 
(8.5: 1.5 Benzene: Acetone); mp 239
0
C; IR (KBr) νmax 3078, 2962, 1676, 1629, 1586, 1103, 729 cm
-1
; 
1
HNMR (CDCl3): δ 
= 3.7 (s, 2H, CH2-N), 6.13-8.77 (m, 13H, ArH);
13
CNMR (CDCl3): δ = 40.6 (CH2-N), 120-150.9 (quinolone, isoindoline and 
phenyl), 163.1 (N=C-O), 169.2 (C=O); EIMS m/z 466(M+), 468(M+1), 438, 362, 355, 294, 280, 266, 238; Anal. Calcd. for 
C26H15ClN4O3: C, 66.95; H, 3.21; N, 11.42. Found: C, 67.38; H, 3.25; N, 12.01. 
 
2-(2-phenylquinolin-4-yl)-5-(2-p-tolylquinoline-4-yl)-1,3,4-oxadiazole (5g): 
Reddish brown solid [Ethanol and Dimethyl Formamide (2:1)] (To synthesized 5g mixture of 2-(4- methyl phenyl)-
quinoline-4-carbohydrazide 1c (0.01 mol), quinoline-carboxylic acid, (0.01 mol) and phosphorus oxychloride (10 ml) was 
refluxed ~ 12h and then followed the above general procedure. It was obtained as a reddish brown solid.); yield ~81 %; Rf 
value: 0.26 (9.0: 1.0 Benzene: Acetone); mp 202-203
0
C; IR (KBr) νmax 3060, 1618, 1588, 1093, 709 cm
-1
; 
1
HNMR 
(CDCl3): δ = 2.66 (s, 3H, CH3), 7.06-8.30 (m, 19H, ArH); 
13
CNMR (CDCl3): δ = 21.09 (CH3), 121-153 (quinoline and 
phenyl), 162.6 (N=C-O of oxadiazole); EIMS m/z 490(M+), 462, 399, 387, 286, 260; Anal. Calcd. for C33H22N4O: C, 80.81; 
H, 4.48; N, 11.42. Found: C, 81.41; H, 4.59; N, 11.49. 
 
2-(furan-2-yl)-5-(2-p-tolylquinolin-4-yl)-1,3,4-oxadiazole (5h): 
Light brown crystals [Ethanol and Dimethyl Formamide (2:1)] (To synthesized 5h mixture of 2-(4- methyl phenyl)-quinoline-
4-carbohydrazide 1c (0.01 mol), furoic acid (0.01 mol) and phosphorus oxychloride (10 ml) was refluxed ~ 12h and then 
followed the above general procedure. It was obtained as a light brown crystals.); yield ~73 %, Rf value, 0.38 (9.0: 1.0 
Benzene: Acetone), mp 175-177
0
C; IR (KBr) νmax 3021, 1637, 1521, 1095, 710 cm
-1
; 
1
HNMR (CDCl3): δ = 2.34 (s, 3H, 
CH3), 6.87-6-8.20 (m, 12H, ArH); 
13
CNMR (CDCl3): δ = 22.09 (CH3), 123.3-156.1(quinoline and phenyl), 164.5 (N=C-O of 
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oxadiazole); EIMS m/z 353(M+), 325, 262, 260, 244, 218, 169; Anal. Calcd. for C22H15N3O3: C, 74.78; H, 4.24; N, 11.89. 
Found: C, 75.01; H, 4.27; N, 11.96. 
 
2-((5-(2-p-tolylquinolin-4-yl)-1,3,4-oxadiazol-2-yl)methyl)isoindoline1,3-dione(5i):  
Light brown crystals [Ethanol and Dimethyl Formamide (2:1)] ( To synthesized 5i mixture of 2-(4- methyl phenyl)-quinoline-
4-carbohydrazide 1c (0.01 mol), phthalimido acetic acid (0.01 mol) and phosphorus oxychloride (10 ml) was refluxed ~ 
12h and then followed the above general procedure. It was obtained as a light brown crystals.); yield ~79 %; Rf value: 
0.29 (9.0: 1.0 Benzene: Acetone); mp 242
0
C; IR (KBr) νmax 3086, 2972, 1668, 1613, 1588, 1109, 712 cm
-1
; 
1
HNMR 
(CDCl3): δ = 2.58 (s, 3H, CH3), 3.89 (s, 2H, CH-N), 6.98-8.72 (m, 13H, ArH); 
13
CNMR (CDCl3): δ = 19.8 (CH3), 42.68 (CH2-
N), 118.9-149.2 (quinoline isoindoline and phenyl), 162.9 (N=C-O of oxadiazole), 166.7 (C=O);  EIMS m/z 446(M+), 418, 
355, 342, 260, 244, 231, 218; Anal. Calcd. for C27H18N4O3: C, 72.69; H, 4.03; N, 12.55. Found: C, 73.30; H, 4.07; N, 
12.66. 
Biological Activity 
Antimicrobial Activity 
All the test compounds were assayed in vitro for their antibacterial activity against Staphylococcus aureus (ATCC-9144), 
Bacillus subtilis (ATCC-6633)  (representative for gram-positive bacteria), Escherichia coli (MTCC-739), 
Pseudomonas aeruginosa (ATCC-25615) and Klebsiella pneumoniae (MTCC-2405) (representative for Gram-negative 
bacteria ), and for their antifungal activity against Candida albicans (ATCC-24433), Aspergillus niger (MTCC-1344), 
Aspergillus fumigatus (MTCC-2544) and Penicillium chrysogenum (MTCC-2725) using disc-diffusion method 
[46]
. The 
MIC was determined by using two fold serial dilution method 
[47,48]
. Gentamicin, Ampicillin and Fluconazole were used as 
reference standards to compare the antibacterial and antifungal activities, respectively. For determining both antibacterial 
and antifungal activities, the synthesized compounds were dissolved in chloroform (stock solution 5mg/mL). In order to 
ensure that the solvent had no effect on bacterial growth, a control test was also performed containing broth supplemented 
with only chloroform at the same dilution used as in our experiment. The solvent used for evaluation of compounds 
exhibited no antimicrobial activity. This property represented a practical advantage for the antimicrobial evaluation of these 
water insoluble compounds.  Further dilution was prepared at the required quantities of 100, 50, 25, 12.5, 6.25 and 3.125 
μg /mL concentration. The MIC values were obtained from the lowest concentration of the test compound where the tubes 
remain clear, indicating that the bacterial growth was completely inhibited at this concentration. The Diameter of zone of 
inhibition is expressed in mm and, MIC values in μg/mL. The results are shown in Table 1. The graphical representations 
are shown in Figure 1 and 2. 
 
Table 1. Antibacterial and Antifungal Activity of Newly Synthesized Compounds (4a-f and 5a-i) MIC Values 
(μg/mL) of Different Strains by Two Fold Serial Dilution Technique and Diameter of Zone of Inhibition (mm) of 
Various Bacterial and Fungal Strains (μg/disc) by Disc-Diffusion Assay 
Compounds S.aureus P.aerug
inosa 
B.subtili
s 
E.coli K.pneumoniae C.albicans A.niger A.fumigatus P.chrysogenum 
4a 25.0  >100
a
 (08) 25.0 
(16) 
50.0 
(12) 
>100
a
 (08) >100
a
 (10) >100 
a
(08) >100
a
 (07) >100
a
 (08) 
4b 3.12
b
 (38) >50.0 (14) >100
a
 
(09) 
>100
a
 
(10) 
>100
a
 (10) 3.12
c 
(40) 50.0 (16) 50.0 (14) >50.0 (10) 
4c 6.25 (32) >50.0 (16) 50.0 
(13) 
50.0 
(14) 
>50.0 (12) 6.25 (27) >100 
a
(12) >100
a
 (08) >50.0 (13) 
4d 25.0 (14) >100
a
 (09) 100
a
 
(08) 
50.0 
(15) 
100
a
(08) 50.0 (14) 100
a
 (08) >100
a
 (10) 100
a
 (09) 
4e >50.0 (11) >100
a
 (10) 6.25 
(23) 
>100
a
(
08) 
>50.0 (13) 50.0 (15) 100
a
 (12) 25.0 (14) >50.0 (12) 
4f 12.5 (18) >100
a
 (12) >50.0 
(10) 
>100
a
 
(08) 
>100
a
 (08) >100
a
 (09) 50.0 (15) >100
a
(12) >100
a
 (08) 
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a No activity. 
b Entries in bold font indicate better activity than reference drugs Gentamicin and Ampicillin (Bauer et al., 1966). 
c Entries in bold font indicate better activity than reference drugs Fluconazole. 
Entries in ( ) indicate zone of inhibition in mm. 
 
5a >100
a
 (08) >100
a
 (12) 100
a
 
(11) 
50.0 
(10) 
>100
a
 (08) 6.25 (22) 6.25 (24) 100
a
 (08) >100
a
 (08) 
5b >50.0 (14) 25.0 (18) >100
a
 
(08) 
50.0 
(15) 
>50.0 (10) 100
a
 (09) >100 
a
(10) >100
a
 (08) >100
a
 (08) 
5c 100
a
 (10) >50.0 (13) >100
a
 
(09) 
>50.0 
(14) 
100
a
(0   9)  
 
6.25 (24) >100
a
(12) >100
a
 (08) >100
a
 (10) 
5d 3.12
b
 (37) 25.0 (19) 50.0 
(10) 
12.5 
(21) 
50.0 (11) 3.12
c
 (39) 25.0 (14) 100
a
 (10) >50.0 (12) 
5e 100
a
 (08) 100
a
 (09) 25.0 
(16) 
25.0 
(19) 
50.0 (13) >50.0 (15) >100 
a
(12) 25.0 (18) >100
a
(08) 
5f 100
a
(09) >100
a
 (16) 25.0 
(17) 
>100
a
 
(08) 
50.0 (15) >100
a
 (09) >100 
a
(10) >100 (08) >100
a
 (10) 
5g 50.0 (14) >100
a
 (10) 6.25 
(25) 
100
a
 
(09) 
>100
a
 (08) >100
a
 (10) 25.0 (16) >50.0 (13) 25.0 (14) 
5h 50.0 (12) 50.0 (12) >100
a
 
(09) 
50.0 
(13) 
>100
a
 (09) 50.0 (14) 100
a
 (12) >100
a
 (10) 100
a
(08) 
5i 6.25 (35) >100
a
 (08) 25.0 
(15) 
25.0 
(16) 
50.0 (11) 6.25 (33) >100 
a
(13) >100
a
 (12) 100
a
 (09) 
Gentam
icin 
6.25 (22) 
 
12.5  (23)    -(22) 12.5    
(20) 
25     (-) - - - - 
Ampicill
in 
6.25      (29)         25         (-)  - 6.25  
(19) 
25     (-) - - - - 
Flucona
zole 
- - - - - 6.25 (21) 6.25 (18) - - 
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Fig 1: Comparative antibacterial study plot with Genatmicin,    Fig 2: Comparative antifungal study plot   
Ampicillin compounds and Pathogens.                                     Fluconazole compounds and Pathogens. 
 
In vitro antibacterial Assay 
The cultures obtained in Muller-Hinton broth for all the bacteria after 24 hr of incubation at 37
0
C. Testing was carried out 
on Muller-Hinton broth at pH 7.4 using two fold serial dilution techniques. The final inoculum size was 106 CFU/mL. A set 
of tubes containing only inoculated broth was kept as control. After incubation for 24h at 37
0
C, the last tube with no growth 
of microorganism was recorded to represent MIC expressed in μg/mL. Every experiment in the antibacterial assay was 
replicated twice in order to define the MIC values. Comparison of antibacterial activity of 4(a-f) and 5(a-i) with that of 
antibacterial drugs, Gentamicin and Ampicillin  showed that compounds 4b and 5d  had better activity while compounds 
4c and 5i exhibited milder activity and compound 4f showed poor activity against Staphylococcus aureus (ATCC-9144). 
Compound 5d also exhibited milder activity against Escherichia coli (MTCC-739). Compound 4b (MIC 3.12μg/mL) and 
5d (MIC 3.12μg/mL) had shown promising antibacterial profiles on comparison with antibacterial drugs, Gentamicin (MIC 
6.25μg/mL) and Ampicillin (MIC 6.25μg/mL), against Staphylococcus aureus (ATCC-9144) (Table 1) as exhibited in Fig 
1. Compounds 4(a-f) and 5(a-i) were also screened against Bacillus subtilis (ATCC-6633), Pseudomonas aeruginosa 
(ATCC-25615), Klebsiella pneumoniae (MTCC-2405), and Escherichia coli (MTCC-739) but did not exhibit significant 
antibacterial activity except 5d, which exhibited milder activity against the mentioned strains.  
In vitro antifungal Assay 
The cultures were obtained in sabouraud dextrose broth after incubation for 24 hr at 35
0
C. Testing was performed in 
sabouraud dextrose broth at pH 7.4 using two fold serial dilution techniques. The final inoculum size was 105 CFU/mL. A 
set of tubes containing only inoculated broth was kept as control. After incubation for 48hr at 35
0
C, the last tube with no 
growth of microorganism was recorded to represent MIC expressed in μg/mL. Every experiment in the antifungal assay 
was replicated twice in order to define the MIC values. Comparison of antifungal activity of compounds 4(a-f) and 5(a-i) 
with that of antifungal drug, Fluconazole, showed that compound 4b  (MIC 3.12μg /mL)and 5d (MIC 3.12μg/mL) had better 
antifungal activity against Candida albicans (ATCC-24433). 4c, 5c, 5i   and 5a exhibited milder antifungal activity against 
Candida albicans (ATCC-24433) and Aspergillus niger (MTCC-1344) respectively. Compound 4b and 5d (MIC 
3.12μg/mL) had shown promising antifungal profiles against Candida albicans (ATCC-24433) as exhibited in Fig  2. 
Compounds 4(a-f) and 5(a-i) were also screened against Aspergillus niger (MTCC-872), Aspergillus fumigatus 
(MTCC-343) and Penicillium chrysogenum (MTCC-2725) but did not exhibit significant antifungal activity except 5a, 
which showed some activity. 
 The compounds tested, exhibited specific antimicrobial activity against different bacterial and fungal strains with MIC 
values in a range of 3.12-100 μg/mL. Many of these compounds showed significant activity comparable to the standard 
drugs at the tested concentrations. The attachment of N-benzoxazine group to 1(a-c) leading to 4(a-c), improved the 
antimicrobial activity, since 4b and 4c possess superior activity than other derivatives 4(d-f) of quinazoline -4- 
carboxamide. The electronic property of para substituent of 2- phenyl ring of quinazoline seems to have slight effect on the 
antimicrobial activity. Both electron withdrawing (Cl) and electron donating (CH3) groups afforded good antimicrobial 
activity. The result suggests that the volume of the substituents may play an important role for the activity as compounds 
with N-benzoxazine structural motif have a good activity than the compounds with bulky N-naphthoxazine group. The 
better activity of 5d can be explained on the basis, that the presence of two quinazoline pharmacophores in a molecule 
reinforces its antimicrobial action. Consistent with these results, compounds 4b and 5d were found to be most potent 
among the tested compounds and exhibited better antimicrobial activity than the clinically prevalent antimicrobial drugs 
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such as Gentamicin, Ampicillin and Fluconazole. Interestingly, all the target compounds were found to be devoid of 
antimicrobial activity against P.aeruginosa, K.pneumoniae, A.fumigatus and P.chrysogenum. 
 In general, compounds 4(b, c& e), 5(a, c, d, g &i), showed significant to moderate activity, whereas rest of the 
compounds are inactive against all tested bacterial as well as fungal strains. 
Conclusion and Future Directions 
A number of new N-(2H-benzo[e][1,3] oxazin-3(4H)-yl)-2-(4-substituted phenyl)quinoline-4-carboxamides or N-(2H-
naphtho[2,3-e][1,3]oxazin-3-(4H)-yl)-2-(4-substitutedphenyl) quinoline-4-carboxamides 4(a-f) and 2,5-bis(2-substituted 
phenyl quinolin-4-yl)-1,3,4-oxadiazoles or 2-(furan-2-yl)-5-(2-(4-substitutedphenyl)quinolin-4-yl)-1,3,4-oxadiazoles or 2-(5-
(2-(4-substituted phenyl) quinolin-4-yl)-1,3,4-oxadiazol-2-yl)methyl)isoindole-1,3-diones 5(a-i) have been prepared as a 
novel group of antimicrobials. In general, compounds 4 (b, c & e), 5 (a, c, d, g & i) showed significant to moderate activity. 
The rest of the compounds showed no sensitivity at their highest tested concentrations against bacterial and fungal 
strains. Compound 4b and 5d were found to be the most active and they may lead to the discovery of potential 
antimicrobial agents and further work is being carried out at Central Drug Research Institute, Lucknow, India, concerning 
its toxicological evaluation. Efforts are paving ways to synthesize more potent biologically active derivatives bearing 
quinoline moiety in their molecular architecture. The mechanism of the antimicrobial activity and further structural 
modifications of the parent structures are presently under investigation to improve their potency as well as selectivity. 
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